<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03476096</url>
  </required_header>
  <id_info>
    <org_study_id>201711067RINC</org_study_id>
    <nct_id>NCT03476096</nct_id>
  </id_info>
  <brief_title>Sublingual Microcirculation Change During Pregnancy and Postpartum Period</brief_title>
  <acronym>Cytocam-OBS</acronym>
  <official_title>Sublingual Microcirculation Change in Pregnant Women With or Without High Risk Pregnancy Factors During Pregnancy and Postpartum Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      Sublingual microcirculation change in pregnant women with or without high risk pregnancy&#xD;
      factors during pregnancy and postpartum period.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Microcirculation system is composed of a group of blood vessels less than 100 um in diameter&#xD;
      composed of arterioles, capillaries, veins and other structures. The health of&#xD;
      microcirculation system correlates well with the stability of systemic circulation. Perfusio&#xD;
      of microcirculation is often affected by major diseases such as sepsis, shock and heart&#xD;
      disease. Through various microcirculation monitoring instruments, the investigators can&#xD;
      assess the disease severity and prognosis.&#xD;
&#xD;
      Physiological changes during pregnancy will increase the blood volume, stroke volume, and&#xD;
      microcirculation. Preeclampsia refers to the development of hypertension (systolic blood&#xD;
      pressure&gt; 140 mmHg, diastolic blood pressure&gt; 90 mmHg) after 20 weeks of gestation with&#xD;
      proteinuria. Severe preeclampsia is associated with impaired endothelial cell circulation&#xD;
      throughout the body, and reduced sublingual microcirculation perfusion.&#xD;
&#xD;
      Through the sublingual microcirculation monitor, studies have shown that pregnant women have&#xD;
      more microcirculation perfusion than non-pregnant women, while women with severe preeclampsia&#xD;
      and those with HELLP syndrome have impaired microcirculation.&#xD;
&#xD;
      This study aims to investigate whether there is any change in the sublingual microcirculation&#xD;
      before and after labor in healthy pregnant women and high-risk pregnant women (such as&#xD;
      epilepsy, gestational diabetes, etc.) through the third generation of microcirculation&#xD;
      imaging microscope (cytocam).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of perfused vessel density</measure>
    <time_frame>From the day before delivery to three days after delivery</time_frame>
    <description>Changes of perfused vessel density before and after delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of microvascular flow index</measure>
    <time_frame>From the day before delivery to three days after delivery</time_frame>
    <description>Changes of microvascular flow index before and after delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of heterogeneity index before</measure>
    <time_frame>From the day before delivery to three days after delivery</time_frame>
    <description>Changes of heterogeneity index before and after delivery</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Microcirculation in Pregnancy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>healthy pregnant women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pre-eclampsia</arm_group_label>
    <description>high-risk pregnant women</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        healthy pregnant women and high-risk pregnant women (gestational diabetes mellitus,&#xD;
        placenta previa, placenta accreta, gestational hypertension, preeclampsia or severe&#xD;
        preeclampsia.)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy pregnant women older than 20 years old who will delivery baby in our hospital&#xD;
             (both normal spontaneous delivery and cesarean section).&#xD;
&#xD;
          -  Women over 20 years of age who will delivery baby in our hospital (both normal&#xD;
             spontaneous delivery and cesarean section) and meet the definition of high-risk&#xD;
             pregnancy such as gestational diabetes mellitus, placenta previa, placenta accreta,&#xD;
             gestational hypertension, preeclampsia or severe preeclampsia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic hypertension or diabetes&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant women</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>YiShiuan Lin</last_name>
    <phone>+886-2-23123456</phone>
    <email>yslin918@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YiShiuan Lin, MD</last_name>
      <phone>+886-2-2312-3456</phone>
      <email>yslin918@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>February 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2018</study_first_posted>
  <last_update_submitted>March 18, 2018</last_update_submitted>
  <last_update_submitted_qc>March 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>microcirculation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

